Holen Sie sich die Stockscreener-App
0.5847
5.59%
-0.0346
Handel nachbörslich:
.55
-0.0347
-5.93%
Schlusskurs vom Vortag:
$0.6193
Offen:
$0.6375
24-Stunden-Volumen:
2.15M
Relative Volume:
0.67
Marktkapitalisierung:
$35.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.35M
KGV:
-1.2839
EPS:
-0.4554
Netto-Cashflow:
$-5.51M
1W Leistung:
+18.91%
1M Leistung:
+12.53%
6M Leistung:
+253.08%
1J Leistung:
+18.82%
1-Tages-Spanne:
$0.5807
$0.665
1-Wochen-Bereich:
$0.4757
$0.665
52-Wochen-Spanne:
$0.1135
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Firmenname
Klotho Neurosciences Inc
Sektor
Branche
Telefon
(833) 931-6330
Adresse
13576 WALNUT STREET, SUITE A, OMAHA
Vergleichen Sie KLTO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.5847 | 38.01M | 0 | -11.35M | -5.51M | -0.4554 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Klotho Neurosciences Inc Aktie (KLTO) Neueste Nachrichten
Klotho Neurosciences Inc. stock volume spike explainedJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - newser.com
Klotho Neurosciences to acquire select assets from Turn Biotechnologies - MSN
Why Klotho Neurosciences Inc. stock appeals to analystsWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
Published on: 2025-10-10 05:36:46 - newser.com
Published on: 2025-10-10 04:03:17 - newser.com
Historical volatility pattern of Klotho Neurosciences Inc. visualizedWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Is Klotho Neurosciences Inc. trending in predictive chart modelsQuarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
Klotho Neurosciences Announces Expiration of Letter of Intent - Eastern Progress
Klotho Neurosciences Announces Expiration Of Letter Of Intent - Barchart.com
Earnings visualization tools for Klotho Neurosciences Inc.Weekly Trade Recap & Entry Point Confirmation Alerts - newser.com
What’s next for Klotho Neurosciences Inc. stock priceExit Point & AI Driven Stock Movement Reports - newser.com
Why Klotho Neurosciences Inc. is moving todayPortfolio Gains Report & Fast Entry Momentum Trade Alerts - newser.com
Will Klotho Neurosciences Inc. stock recover after recent dropJuly 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
How strong is Klotho Neurosciences Inc. Equity Warrant stock balance sheet2025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Combining price and volume data for Klotho Neurosciences Inc.Quarterly Profit Report & Fast Gain Swing Trade Alerts - newser.com
How sentiment analysis helps forecast Klotho Neurosciences Inc. Equity WarrantProfit Target & Advanced Swing Trade Entry Alerts - newser.com
Visual trend scoring systems applied to Klotho Neurosciences Inc.2025 Price Targets & AI Driven Stock Movement Reports - newser.com
How to use a screener to detect Klotho Neurosciences Inc. breakoutsAnalyst Downgrade & Daily Volume Surge Signals - newser.com
Is Klotho Neurosciences Inc. Equity Warrant forming a reversal pattern2025 Top Gainers & Reliable Price Breakout Alerts - newser.com
Reversal indicators forming on Klotho Neurosciences Inc. Equity Warrant stockJuly 2025 Patterns & Stock Portfolio Risk Management - newser.com
Can swing trading help recover from Klotho Neurosciences Inc. lossesJuly 2025 Short Interest & Long-Term Growth Plans - newser.com
Klotho Neurosciences to Acquire Longevity Therapeutic Assets from Turn Biotechnologies - Contract Pharma
Using R and stats models for Klotho Neurosciences Inc. Equity Warrant forecastingPortfolio Update Report & Technical Confirmation Alerts - newser.com
Klotho Neurosciences signs LOI to acquire Turn Bio assets By Investing.com - Investing.com Nigeria
Klotho Neurosciences Signs Letter of Intent to Acquire Select As - GuruFocus
Finanzdaten der Klotho Neurosciences Inc-Aktie (KLTO)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):